United Therapeutics Target Price

See United Therapeutics's analyst price targets ($630) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$501.27

Average Target Price

$626.00

24.9% upside

4 analysts in the last 4 months

High: $738 | Low: $515

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-06	Morgan StanleyTerence Flynn	$515	2.7% upside
2026-05-07	Morgan StanleyTerence Flynn	$516	2.9% upside
2026-05-07	Wells Fargo	$735	46.6% upside
2026-05-07	Wells Fargo	$738	47.2% upside
2026-04-10	Morgan StanleyTerence Flynn	$519	3.5% upside
2026-04-10	Raymond James	$700	39.6% upside
2026-03-12	Cantor FitzgeraldOlivia Brayer	$625	24.7% upside
2026-02-26	H.C. WainwrightAndrew Fein	$600	19.7% upside
2026-01-06	UBS	$645	28.7% upside
2025-11-19	JefferiesEun Yang	$575	14.7% upside
2025-10-30	H.C. WainwrightAndrew Fein	$525	4.7% upside
2025-10-30	RBC CapitalLisa Walter	$587	17.1% upside
2025-10-29	Morgan StanleyTerrance Flynn	$447	10.8% downside
2025-10-10	Morgan StanleyTerence Flynn	$435	13.2% downside
2025-09-29	UBS	$580	15.7% upside
2025-09-26	RBC Capital	$569	13.5% upside
2025-09-10	Cantor FitzgeraldOlivia Brayer	$525	4.7% upside
2025-09-05	H.C. WainwrightAndrew Fein	$500	0.3% downside
2025-09-02	JefferiesRoger Song	$564	12.5% upside
2025-07-31	H.C. WainwrightAndrew Fein	$400	20.2% downside
2025-04-25	Wells FargoTiago Fauth	$314	37.4% downside
2024-10-31	Argus ResearchJasper Hellweg	$400	20.2% downside
2024-10-31	H.C. WainwrightAndrew Fein	$425	15.2% downside
2024-09-23	JefferiesEun Yang	$432	13.8% downside
2024-08-28	OppenheimerHartaj Singh	$575	14.7% upside
2024-07-08	UBSAshwani Verma	$370	26.2% downside
2024-06-12	Wells FargoTiago Fauth	$350	30.2% downside
2024-05-02	OppenheimerHartaj Singh	$400	20.2% downside
2024-02-12	Goldman SachsChris Shibutani	$215	57.1% downside
2023-01-11	Argus Research	$300	40.2% downside
2022-12-06	Morgan Stanley	$330	34.2% downside
2022-12-06	UBS	$320	36.2% downside
2022-12-05	Goldman Sachs	$230	54.1% downside
2022-05-24	J.P. Morgan	$238	52.5% downside
2022-05-24	Jefferies	$245	51.1% downside
2022-05-24	Credit Suisse	$247	50.7% downside
2022-05-24	H.C. Wainwright	$255	49.1% downside
2022-04-19	J.P. Morgan	$223	55.5% downside
2021-05-05	Credit SuisseTiago Fauth	$205	59.1% downside

United Therapeutics (UTHR) FAQ

The latest target price for UTHR is $630. Investors often review this figure alongside United Therapeutics's historical trend and sector peers before judging valuation or financial health.

United Therapeutics trades near $501.27 while the consensus target sits at $630 (24.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting UTHR's target price ($630), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack United Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.